-
Scioto Biosciences Receives Series B Investment from Genome & Company
-
Scioto Biosciences and Abigail Wexner Research Institute at Nationwide Children’s Hospital Receive a $2.3 Million Dollar Phase II SBIR Grant to Develop Novel Therapy
-
Global Genes RARE Cast
Learning New Tricks from Pathogenic Bacteria to Target the Microbiome